
© 2025 Moneycab
Realtime | Geld | Brief | Zeit |
---|---|---|---|
280,00 | 281,30 | 07:37 | |
0,000 | 0,000 | 28.03.23 |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
07:29 | Genentech:Phase III Data Shows Single-Dose Xofluza Effectively Reduces Influenza Transmission By 32% | ||
07:10 | F. Hoffmann-La Roche Ltd: New England Journal of Medicine publishes phase III data showing single-dose Xofluza significantly reduces influenza virus transmission | Detailed results from the CENTERSTONE trial show treatment with Xofluza reduced the odds of transmission, or spread of the influenza virus, from an infected person to household members by 32%1CENTERSTONE... ► Artikel lesen | |
Do | Zealand Pharma gains as trial for Roche-partnered obesity drug starts | ||
Do | Roche Stock: Pharma Growth Offsets Diagnostic Challenges | ||
Do | Roche's Q1 Sales Increase Y/Y on Solid Performance of Key Drugs |